BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20398866)

  • 1. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac magnetic resonance imaging to assess and predict improvement of myocardial function after percutaneous coronary intervention: a new standard?
    Kutcher MA
    JACC Cardiovasc Interv; 2010 Apr; 3(4):401-2. PubMed ID: 20398867
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between transmural extent of necrosis and quantitative recovery of regional strains after revascularization.
    Gerber BL; Darchis J; le Polain de Waroux JB; Legros G; Pouleur AC; Vancraeynest D; Pasquet A; Vanoverschelde JL
    JACC Cardiovasc Imaging; 2010 Jul; 3(7):720-30. PubMed ID: 20633850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function.
    Bollati M; Gerasimou A; Sillano D; Biondi-Zoccai G; Garrone P; Moretti C; Sciuto F; Omedé P; Trevi GP; Sheiban I
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):586-93. PubMed ID: 20088012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction.
    Abdel-Salam Z; Nammas W
    Cardiovasc Revasc Med; 2010; 11(1):2-7. PubMed ID: 20129355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation.
    Freixa X; Chan J; Bonan R; Ibrahim R; Lamarche Y; Demers P; Basmadjian A; Ibrahim R; Cartier R; Asgar AW
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):450-8. PubMed ID: 25115215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
    BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
    Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study.
    Wong DT; Leung MC; Das R; Puri R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):746-53. PubMed ID: 22422674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dysfunctional remote myocardium in left ventricular anterior aneurysms and improvements following surgical ventricular restoration using cardiac magnetic resonance imaging: preliminary results.
    Adhyapak SM; Menon PG; Parachuri VR; Shetty DP; Fantini F
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):368-74. PubMed ID: 24907238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time assessment of myocardial viability in the catheterization laboratory using the intracoronary electrograms recorded by the PTCA guidewire in patients with left ventricular dysfunction: comparison with delayed-enhancement magnetic resonance imaging.
    Petrucci E; Balian V; Bocchieri A
    JACC Cardiovasc Interv; 2014 Sep; 7(9):988-96. PubMed ID: 25129666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions.
    Baks T; van Geuns RJ; Duncker DJ; Cademartiri F; Mollet NR; Krestin GP; Serruys PW; de Feyter PJ
    J Am Coll Cardiol; 2006 Feb; 47(4):721-5. PubMed ID: 16487835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism.
    Pasquet A; Lauer MS; Williams MJ; Secknus MA; Lytle B; Marwick TH
    Eur Heart J; 2000 Jan; 21(2):125-36. PubMed ID: 10637086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic levels of endothelin correlate with systemic inflammation and not with myocardial injury or left ventricular ejection fraction in patients undergoing percutaneous coronary intervention and on-pump coronary artery bypass grafting.
    Cuculi F; Lim CC; van Gaal W; Testa L; Westaby S; Arnold JR; Neubauer S; Banning AP
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):585-9. PubMed ID: 21908890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CINE-MRT for the study of the effects of regional left ventricular wall motion disorders on global heart function after a myocardial infarct and revascularization].
    Sandstede J; Lipke C; Beer M; Harre K; Pabst T; Kenn W; Neubauer S; Hahn D
    Rofo; 1999 Dec; 171(6):424-30. PubMed ID: 10668506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation.
    Glaveckaite S; Valeviciene N; Palionis D; Skorniakov V; Celutkiene J; Tamosiunas A; Uzdavinys G; Laucevicius A
    J Cardiovasc Magn Reson; 2011 Jul; 13(1):35. PubMed ID: 21787383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.